Mitsui Global Investment — 2017 Investments
1 investments dated 2017 · listed companies and verified rows first · show all
Actimis Pharmaceuticals IncMar 2017Acquired
Biotech developing small-molecule therapies for respiratory, inflammatory and autoimmune diseases, acquired by Boehringer Ingelheim.
BiotechSan Mateo, US
Peter McWilliams(Executive Officer, Director)Kevin Bacon(Executive Officer, Director)
BoardFred Middleton(Director)Masaji Matsuoka(Director)in
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.